Please login to the form below

Not currently logged in
Email:
Password:

Maxcess Managed Markets appoints new MD

James Harmon has been appointed as managing director and executive vice president of Maxcess Managed Markets

James Harmon has been appointed as managing director and executive vice president of Maxcess Managed Markets, a speciality provider of strategic market insight, planning, research, and communications services to the pharmaceutical industry.

Harmon has more than 20 years of experience in the pharmaceutical industry with managed markets, marketing, global market access, sales leadership, customer management, commercial development and operations experience.

Most recently Harmon was an executive advisor with the managed markets practice and the pharmaceutical institute for Campbell Alliance, whose clients include top-tier pharmaceutical and biotech companies as well as smaller and growing firms.

Prior to Campbell Alliance, Harmon served as vice president of Managed Markets and was a member of the executive leadership team for Organon, US. At Organon, he led the managed markets transformation from a tactical to strategic function that was fully integrated across the marketing and sales organisations, generating significant financial results, strategic process and marketing improvements for the company.

Mike Trepicchio, president of Publicis Health Care Communications Group (PHCG) North America Advertising, of which Maxcess is a subsidiary, said: "Market access is an increasingly critical issue, as health 2.0 and environmental constraints pressure the pharmaceutical industry to evolve its economic model as well as its customers."

He continued: "Jim's talent for 'demystifying' managed markets and engaging all stakeholders for success and shared accountability makes him the perfect fit at the helm of Maxcess."

Harmon said: "Maxcess' disciplined approach to managed markets marketing and results-driven philosophy make the firm an industry standout. I am eager to leverage my experience and that of the Maxcess teams to add to the intellectual value capital driving our clients' success."

8th April 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics